124.60
-0.03 (-0.02%)
| Previous Close | 124.63 |
| Open | 125.49 |
| Volume | 58,894 |
| Avg. Volume (3M) | 259,727 |
| Market Cap | 4,481,961,472 |
| Price / Earnings (TTM) | 64.23 |
| Price / Sales | 4.39 |
| Price / Book | 5.23 |
| 52 Weeks Range | |
| Earnings Date | 5 Aug 2025 |
| Profit Margin | 7.42% |
| Operating Margin (TTM) | 12.84% |
| Diluted EPS (TTM) | 1.95 |
| Quarterly Revenue Growth (YOY) | 1.10% |
| Quarterly Earnings Growth (YOY) | 44.50% |
| Total Debt/Equity (MRQ) | 57.49% |
| Current Ratio (MRQ) | 2.56 |
| Operating Cash Flow (TTM) | 157.37 M |
| Levered Free Cash Flow (TTM) | 152.43 M |
| Return on Assets (TTM) | 5.75% |
| Return on Equity (TTM) | 9.73% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Scientific & Technical Instruments (US) | Bullish | Mixed |
| Scientific & Technical Instruments (Global) | Bullish | Mixed | |
| Stock | Novanta Inc. | Bearish | Bearish |
AIStockmoo Score
| Analyst Consensus | -0.5 |
| Insider Activity | NA |
| Price Volatility | 1.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -2.5 |
| Average | 0.13 |
|
Novanta Inc manufactures photonic and motion-control components for original equipment manufacturers in the medical equipment and industrial technology markets. The firm operates in two segments: Automation Enabling Technologies and Medical Solutions. It generates the majority of its revenue from the Medical Solutions segment that designs, manufactures, and markets a range of medical-grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; and wireless technologies. The firm generates the majority of its revenue from the United States and Europe. |
|
| Sector | Technology |
| Industry | Scientific & Technical Instruments |
| Investment Style | Small Growth |
| % Held by Insiders | 0.86% |
| % Held by Institutions | 105.06% |
| 52 Weeks Range | ||
| Median | 133.00 (6.74%) | |
| Total | 1 Hold | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Baird | 11 Aug 2025 | 133.00 (6.74%) | Hold | 113.14 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 12 Aug 2025 | Announcement | Novanta to Present at Baird 2025 Global Healthcare Conference on Tuesday, September 9, 2025 |
| 05 Aug 2025 | Announcement | Novanta Announces Financial Results for the Second Quarter 2025 |
| 08 Jul 2025 | Announcement | Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, August 5, 2025 |
| 12 Jun 2025 | Announcement | Novanta to Present at the CJS Securities 25th Annual New Ideas Summer Conference on Thursday, July 10, 2025 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |